https://advvivekramteke.blogspot.com/2021/05/legal-notice-upon-dr-soumya-swaminathan.html legal notice is served by Indian Bar Association (IBA) upon Dr. Soumya Swaminathan, the Chief Scientist at the World Health Organisation (WHO) on May 25, 2021. ..The notice is based on the research and clinical trials carried out by ‘Front Line COVID-19 Critical Care Alliance’ (FLCCC) and the British Ivermectin Recommendation Development (BIRD) Panel. Dr. Soumya Swaminathan (allegedly) has ignored these studies/reports..
the Indian Council for Medical Research (ICMR) and All India Institute of Medical Sciences (AIIMS), Delhi ..have retained the recommendation for Ivermectin under ‘May Do’ category, for patients with mild symptoms and those in home isolation, as stated in ‘The National Guidelines for COVID-19 management’ last updated on May 17, 2021.
Legal Notice to Dr. Soumya Swaminathan (Chief Scientist WHO): https://drive.google.com/file/d/1X7hH1jncsRGsy77gpUg21yIXsQRJOEvP/view?usp=sharing
https://www.merck.com/news/merck-statement-on-ivermectin-use-during-the-covid-19-pandemic/ Company scientists continue to carefully examine the findings of all available and emerging studies of ivermectin for the treatment of COVID-19 for evidence of efficacy and safety. It is important to note that, to-date, our analysis has identified:
No scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies;
No meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease, and;
A concerning lack of safety data in the majority of studies.
Swaminathan's Interview on 16th May https://youtu.be/N2lNIYXrLlA?t=549 mainly talks about the fear of Prolonged Second Wave. She also called for safe disposal of bodies .
In the petition, Dr Swaminathan speaks about "wide spread use" of several drugs and she names Ivermectin among six drugs. https://youtube.com/embed/N2lNIYXrLlA?start=1420&end=1685
https://twitter.com/doctorsoumya
Soumya Swaminathan Retweeted Carl Zimmer
27 May
Ivermectin "is not a viable option to treat COVID-19 patients.” [Preprint of meta-analysis] https://www.medrxiv.org/content/10.1101/2021.05.21.21257595v1
Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized...
Background: We systematically assessed benefits and harms of the use of ivermectin (IVM) in COVID-19 patients. Methods: Published and preprint randomized controlled trials (RCTs) assessing IVM...
medrxiv.org